Related Experiment Video
Updated: Jun 8, 2026
07:26
Generation of Organotypic Raft Cultures from Primary Human Keratinocytes
Published on: February 22, 2012
Evolution of human papillomavirus carcinogenicity
Koenraad Van Doorslaer1, Robert D Burk
1Department of Microbiology and Immunology, Albert Einstein Cancer Center, Albert Einstein College of Medicine, New York, USA.
Advances in Virus Research
|October 19, 2010
Summary
Understanding the molecular basis of oncogenic human papillomavirus (HPV) types is crucial. This review proposes using evolutionary and epidemiological frameworks with functional assays to differentiate carcinogenic from non-carcinogenic HPV strains.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Alphapapillomavirus genus, including human papillomavirus (HPV), causes cervical cancer.
- HPV types exhibit a spectrum of pathogenicity, from highly carcinogenic (e.g., HPV16) to non-carcinogenic (e.g., HPV71).
- HPV16 oncoproteins (E6 and E7) are necessary and sufficient for keratinocyte transformation in vitro.
Purpose of the Study:
- To explore the molecular mechanisms differentiating oncogenic from non-oncogenic HPV types.
- To advocate for an evolutionary and epidemiological framework for understanding HPV pathogenicity.
- To interpret recent findings within this proposed paradigm.
Main Methods:
- Review of existing literature on HPV oncoprotein functions.
- Functional assays to compare HPV types.
- Analysis within an evolutionary and epidemiological context.
Main Results:
- Direct functional comparisons between HPV types may not fully elucidate pathogenicity differences.
- An integrated approach combining functional assays with evolutionary and epidemiological data is proposed.
- Recent results are re-interpreted through this proposed framework.
Conclusions:
- Understanding HPV pathogenicity requires a framework that integrates molecular mechanisms with evolutionary and epidemiological data.
- Future research should focus on functional assays within this broader context.
- This approach will provide a more nuanced understanding of HPV-driven carcinogenesis.
Related Concept Videos
00:36Viral Mutations
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:51Mechanisms of Retrovirus-induced Cancers
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...